ISAD Turns Attention to a Frequently Overlooked Member of the Atopic Dermatitis Care Team: The Pharmacist
ISAD’s September Digest highlights Beijing 2026, the role of pharmacists in atopic dermatitis care, and new research shaping …
Three-Year Nemolizumab Data Show Sustained Improvements in Skin, Itch and Sleep
Three-year ARCADIA data show sustained improvements with Nemluvio in skin lesions, itch, sleep and quality of life in …
Eczema Patients Take Their Stories Directly to U.S. Congress — and Advocacy Produces an Early Result
Eczema advocates held 61 meetings with U.S. congressional offices, calling for better treatment access, insurance reform and continued …
Australia Expands Eczema Access as Tacrolimus Ointment Joins the PBS
Australia will add tacrolimus 0.1% ointment (Zematop) to the PBS, giving more than 143,000 people with moderate-to-severe atopic …
European Parliament Recognises Women's Skin Health Burden
MEPs have for the first time acknowledged the disproportionate impact of skin diseases on women and girls, and …
Early-Onset and Late-Onset Atopic Dermatitis May Not Be the Same Disease Biologically
EADV’s 2026 Congress spotlight highlights advances in atopic dermatitis, from early- and late-onset disease to childhood eczema and …
